期刊文献+

CRISPR-Cas9基因编辑系统研究进展 被引量:4

Progress on CRISPR-Cas9 System
下载PDF
导出
摘要 由规律成簇间隔短回文重复序列(CRISPR)和CRISPR相关蛋白(CRISPR-associated protein)组成的CRISPR-Cas系统是细菌一种重要的获得性免疫系统。经改造的CRISPR-Cas9系统可在真核生物和原核生物、病毒等基因组内实现目的基因的插入、缺失。尽管由于受到单链引导RNA(single guide RNA,sgRNA)识别序列具有特异性的限制,同时一些物种基因结构存在复杂性和特异性,在基因编辑过程中会出现脱靶现象,在一定程度上限制了CRISPR-Cas9系统更加广泛的应用。但是,CRISPR-Cas9系统已经展现出很强的基因编辑能力,提升科研人员基因编辑的能力,是一项极具有应用潜质的新技术。论文主要阐述了CRISPR-Cas9系统结构、组成、设计策略和应用等方面研究进展,为相关科学的研究提供参考。 The CRISPR(clustered regularly interspaced short palindromic repeats)-Cas(CRISPR associated protein)system is an important adaptive immune system in microbiology.The typeⅡCRISPR-Cas9 system,which is best characterized,is applied in many biology including the prokaryote,eukaryote and virus.Although there are the limitations of sgRNA(single guide RNA)specificity and genome complexity of some species,and off-target problems in application,CRISPR-Cas9 system is still a promising tool in gene editing.Herein,we reviewed the components and applications of CRISPR-Cas9 in order to provide a theoretical basis for further understanding it.
作者 孙伟 刘杉杉 SUN Wei;LIU Shan-shan(College of Agriculture,Tongren Polytechnic College,Tongren,Guizhou,554300,China;National and Local Engineering Research Centre for Separation and Purification Ethnic Chinese Veterinary Herbs,Tongren Polytechnic College,Tongren,Guizhou,554300,China)
出处 《动物医学进展》 北大核心 2018年第8期93-96,共4页 Progress In Veterinary Medicine
基金 铜仁市科技计划项目(铜市科研[2016]17号-5)
关键词 规律成簇间隔短回文重复序列 真核生物 原核生物 基因编辑 clustered regularly interspaced short palindromic repeats prokaryote eukaryote gene editing
  • 相关文献

参考文献3

二级参考文献52

  • 1Saayman S, Ali SA, Morris KV, Weinberg MS. The therapeutic application of CRISPR/Cas9 technologies for HIV. Expert Opin Biol Ther , 2015, 15(6): 819-830.
  • 2Gaj T, Gersbach CA, Barbas III CF. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol , 2013, 31(7): 397-405.
  • 3Cai M, Yang Y. Targeted genome editing tools for disease modeling and gene therapy. Curr Gene Ther , 2014, 14(1): 2-9.
  • 4DiGiusto DL, Krishnan A, Li LJ, Li HT, Li S, Rao A, Mi S, Yam P, Stinson S, Kalos M, Alvarnas J, Lacey SF, Yee JK, Li MJ, Couture L, Hsu D, Forman SJ, Rossi JJ, Zaia JA. RNA-based gene therapy for HIV with lentiviral vector-modified CD34 + cells in patients undergoing transplantation for AIDS-related lymphoma. Sci Transl Med , 2010, 2(36): 36RA43.
  • 5Chung J, Scherer LJ, Gu A, Gardner AM, Torres-Coronado M, Epps EW, DiGiusto DL, Rossi JJ. Optimized lentiviral vectors for HIV gene therapy: multiplexed expression of small RNAs and inclusion of MGMT P140K drug resistance gene. Mol Ther , 2014, 22(5): 952-963.
  • 6Mojica FJ, Díez-Villaseñor C, García-Martínez J, Almendros C. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology , 2009, 155(Pt 3): 733-740.
  • 7Mojica FJM, Díez-Villaseñor C, García-Martínez J, Soria E. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol , 2005, 60(2): 174-182.
  • 8Strong CL, Guerra HP, Mathew KR, Roy N, Simpson LR, Schiller MR. Damaging the integrated HIV proviral DNA with TALENs. PLoS One , 2015, 10(5): e0125652.
  • 9Ye L, Wang JM, Beyer AI, Teque F, Cradick TJ, Qi ZX, Chang JC, Bao G, Muench MO, Yu JW, Levy JA, Kan YW. Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection. Proc Natl Acad Sci USA , 2014, 111(26): 9591-9596.
  • 10Yi G, Choi JG, Bharaj P, Abraham S, Dang Y, Kafri T, Alozie O, Manjunath MN, Shankar P. CCR5 gene editing of resting CD4 + T cells by transient ZFN expression from HIV envelope pseudotyped nonintegrating lentivirus confers HIV-1 resistance in humanized mice. Mol Ther Nucleic Acids , 2014, 3: e198.

共引文献48

同被引文献29

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部